《中华医学科研管理》杂志

文章摘要

剑桥大学生物医学科研管理探讨

Management of Biomedical Research at the University of Cambridge: Implications for China

投稿时间：2016-10-01 修订日期：2016-10-08

DOI：

英文关键词: University of Cambridge Biomedicine Research Management

基金项目:国家留学基金(CSC NO.201406015022)；国家社科“青蒿素研发中的管理模式与科研评价研究”(12BGL114)

作者	单位	E-mail
陈琦	北京大学医学人文研究院/公共教学部	chenqi@bjmu.edu.cn
黎润红	北京大学医学人文研究院/公共教学部	lirunhong@bjmu.edu.cn

摘要点击次数: 2220

中文摘要:

中国科学家因在特殊年代研发的青蒿素而获得诺贝尔奖,引发了对我国新时代生物医学科研管理策略的探讨。科学研究已进入大科学时代,对传统的科研管理模式提出了挑战。剑桥大学的生物医学成果显著,其科研管理体系较为完善,本文在介绍其科研管理经验的基础上,结合我国现状提出了相关建议。

英文摘要:

In China, the winning of the Nobel Prize in Physiology or Medicine by the Chinese scientist TU Youyou for artemisinin that was discovered during the 1970s triggered a discussion about developing a biomedical research management strategy in the new era. Traditional management has faced many challenges in the era of Big Science. The University of Cambridge has attained remarkable achievements in biomedical research and has an effective management system. By referencing observations from Cambridge, and considering the research climate in China, this article proposes strategies for advancing research management in Chinese universities.

查看/发表评论下载PDF阅读器